Viewing Study NCT02211261


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2026-02-02 @ 9:09 PM
Study NCT ID: NCT02211261
Status: COMPLETED
Last Update Posted: 2018-10-16
First Post: 2014-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-09-15
Start Date Type: ACTUAL
Primary Completion Date: 2017-01-27
Primary Completion Date Type: ACTUAL
Completion Date: 2017-01-27
Completion Date Type: ACTUAL
First Submit Date: 2014-08-06
First Submit QC Date: None
Study First Post Date: 2014-08-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-01-22
Results First Submit QC Date: None
Results First Post Date: 2018-10-16
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-10-15
Last Update Post Date: 2018-10-16
Last Update Post Date Type: ACTUAL